CHD4 and neoplasm: A NuRD-targeted CRISPR-Cas9 screen revealed that FP-RMS cells are uniquely sensitive to CHD4 depletion compared to other NuRD components, indicating a non-redundant, lineage-specific role for CHD4 in this tumor type [202].